Showing results (571-580 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|January 23, 2016
Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck CancerIlir Agalliu, Susan Gapstur, Zigui Chen, et al.
JAMA Oncology|January 30, 2016
Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid TumorsD Williams Parsons, Angshumoy Roy, Yaping Yang, et al.
JAMA Oncology|February 11, 2016
Familial Risk in Patients With Carcinoma of Unknown PrimaryN Jewel Samadder, Ken Robert Smith, Heidi Hanson, et al.
JAMA Oncology|February 13, 2016
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal CancerJenny F Seligmann, Faye Elliott, Susan D Richman, et al.
JAMA Oncology|November 19, 2020
Nonpharmacological Interventions for Managing Breathlessness in Patients With Advanced Cancer: A Systematic ReviewArjun Gupta, Ramy Sedhom, Ritu Sharma, et al.
JAMA Oncology|November 5, 2020
Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical TrialFrançois-Clément Bidard, William Jacot, Nicolas Kiavue, et al.
JAMA Oncology|November 5, 2020
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical TrialVeronica Mariotti, Hyo Han, Roohi Ismail-Khan, et al.
JAMA Oncology|November 12, 2020
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical TrialEhab Atallah, Charles A Schiffer, Jerald P Radich, et al.
JAMA Oncology|March 6, 2020
Incidence and Mortality Risk Spectrum Across Aggressive Variants of Papillary Thyroid CarcinomaAllen S Ho, Michael Luu, Laurel Barrios, et al.
JAMA Oncology|February 21, 2020
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical TrialJavier Martin-Broto, Nadia Hindi, Antonio Lopez-Pousa, et al.
Pageof 161